Who owns WEN Acquisition Corp?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of WENNU from SEC Form 13F filings across 9 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 9 institutions disclosed 952,049 shares of WEN Acquisition Corp worth $9.9M — about 3.2% of shares outstanding; the largest disclosed holder is TORONTO DOMINION BANK. Source: SEC Form 13F filings, parsed by EvidInvest.
9
13F holders
$9.9M
value, 2026 filers
3.2%
of shares outstanding (952,049 sh)
0
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of WENNU's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | TORONTO DOMINION BANK | 372,200 | $3.9M | 0.0% | 1.2% | +15.5% |
| 2 | OMERS ADMINISTRATION Corp | 227,931 | $2.4M | 0.0% | 0.8% | 0.0% |
| 3 | Yakira Capital Management, Inc. | 130,272 | $1.4M | 0.4% | 0.4% | 0.0% |
| 4 | Clear Street Group Inc. | 122,123 | $1.3M | 0.0% | 0.4% | +62.9% |
| 5 | JPMORGAN CHASE & CO | 50,000 | $521,000 | 0.0% | 0.2% | 0.0% |
| 6 | Walleye Capital LLC | 31,124 | $324,312 | 0.0% | 0.1% | 0.0% |
| 7 | Lineage Point Capital LP | 10,000 | $107,050 | 0.0% | 0% | 0.0% |
| 8 | GLAZER CAPITAL, LLC | 8,214 | $88,000 | 0.0% | 0% | 0.0% |
| 9 | UBS Group AG | 185 | $1,926 | 0.0% | 0% | -2.1% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation. Research, not investment advice.